Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum-Reference-Cited by-同舟云学术

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum

Published:2021-10-14 Issue: Volume: Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Tosun Duygu¹²^ORCID,Demir Zeynep²,Veitch Dallas P.¹²,Weintraub Daniel³,Aisen Paul⁴,Jack Clifford R.⁵,Jagust William J.⁶,Petersen Ronald C.⁷⁸,Saykin Andrew J.⁹¹⁰¹¹,Shaw Leslie M.¹²,Trojanowski John Q.¹²,Weiner Michael W.¹²,

Affiliation:

1. San Francisco Veterans Affairs Medical Center San Francisco California USA

2. Department of Radiology and Biomedical Imaging University of California San Francisco San Francisco California USA

3. Department of Psychiatry University of Pennsylvania Philadelphia Pennsylvania USA

4. Alzheimer's Therapeutic Research Institute (ATRI) Keck School of Medicine University of Southern California San Diego California USA

5. Department of Radiology Mayo Clinic Rochester Minnesota USA

6. School of Public Health and Helen Wills Neuroscience Institute University of California, Berkeley Berkeley California USA

7. Division of Epidemiology Department of Health Sciences Research Mayo Clinic Rochester Minnesota USA

8. Department of Neurology Mayo Clinic Rochester Minnesota USA

9. Center for Neuroimaging Department of Radiology and Imaging Sciences Indiana University School of Medicine Indianapolis Indiana USA

10. Indiana Alzheimer Disease Center Indiana University School of Medicine Indianapolis Indiana USA

11. Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis Indiana USA

12. Department of Pathology and Laboratory Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12480

Reference56 articles.

1. Clinical development of aducanumab, an anti‐aβ human monoclonal antibody being investigated for the treatment of early Alzheimer's disease;Budd Haeberlein S;J Prev Alzheimers Dis,2017

2. Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

3. To what degree is late life cognitive decline driven by age-related neuropathologies?

4. Person-specific contribution of neuropathologies to cognitive loss in old age

5. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. White matter hyperintensity on MRI and plasma Aβ42/40 ratio additively increase the risk of cognitive impairment in hypertensive adults;Alzheimer's & Dementia;2024-09-04

2. Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity;Alzheimer's Research & Therapy;2024-08-19

3. Impact of Helicobacter pylori eradication on age-specific risk of incident dementia in patients with peptic ulcer disease: a nationwide population-based cohort study;GeroScience;2024-08-12

4. Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimer’s disease;2024-07-23

5. Dynamic associations between tau aggregation, atrophy, and cognitive decline in Alzheimer’s disease;2024-07-21